NCT00087282View on ClinicalTrials.gov

Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2004

Study Completion Date

July 31, 2006

Conditions
Liver Cancer
Interventions
DRUG

alvocidib

DRUG

irinotecan hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00087282 - Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer | Biotech Hunter | Biotech Hunter